Candida Research Today is a free monthly online journal that collates and summarizes the latest research about Candida, including details on thrush infections, yeast, diet, treatment, symptoms.

Volume 2 (2005), Issue 1 (January)

1. Generation and functional in vivo characterization of a lipid kinase defective phosphatidylinositol 3-kinase Vps34p of Candida albicans.
   Microbiology, 151: 81-9. [Abstract] [Full-text]
2. Secondary structure, conformational stability and glycosylation of a recombinant Candida rugosa lipase studied by Fourier-transform infrared spectroscopy.
   Biochem J, 385: 511-7. [Abstract] [Full-text]
3. Comparison of a new commercial test, GLABRATA RTT, with a dipstick test for rapid identification of Candida glabrata.
   J Clin Microbiol, 43(1): 499-501. [Abstract] [Full-text]
4. Effect of inoculum size on detection of Candida growth by the BACTEC 9240 automated blood culture system using aerobic and anaerobic media.
   J Clin Microbiol, 43(1): 433-5. [Abstract] [Full-text]
5. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III.
   J Clin Microbiol, 43(1): 284-92. [Abstract] [Full-text]
6. Multigene phylogenetic analysis of pathogenic candida species in the Kazachstania (Arxiozyma) telluris complex and description of their ascosporic states as Kazachstania bovina sp. nov., K. heterogenica sp. nov., K. pintolopesii sp. nov., and K. slooffiae sp. nov.
   J Clin Microbiol, 43(1): 101-11. [Abstract] [Full-text]
7. In vitro activity of bergamot natural essence and furocoumarin-free and distilled extracts, and their associations with boric acid, against clinical yeast isolates.
   J Antimicrob Chemother, 55(1): 110-4. [Abstract] [Full-text]
8. Rapid flow-cytometric susceptibility testing of Candida species.
   J Antimicrob Chemother, 55(1): 106-9. [Abstract] [Full-text]
9. Toll-like receptor 2 mediates prostaglandin E(2) production in murine peritoneal macrophages and splenocytes in response to Candida albicans.
   Res Microbiol, 156(1): 115-8. [Abstract] [Full-text]
10. Demonstration of loss of heterozygosity by single-nucleotide polymorphism microarray analysis and alterations in strain morphology in Candida albicans strains during infection.
    Eukaryot Cell, 4(1): 156-65. [Abstract] [Full-text]
11. Cyclin Cln3p links G1 progression to hyphal and pseudohyphal development in Candida albicans.
    Eukaryot Cell, 4(1): 95-102. [Abstract] [Full-text]
12. The G1 cyclin Cln3 regulates morphogenesis in Candida albicans.
    Eukaryot Cell, 4(1): 90-4. [Abstract] [Full-text]
13. Mnt1p and Mnt2p of Candida albicans are partially redundant alpha-1,2-mannosyltransferases that participate in O-linked mannosylation and are required for adhesion and virulence.
    J Biol Chem, 280(2): 1051-60. [Abstract] [Full-text]
14. 5-Fluoro-orotic acid induces chromosome alterations in Candida albicans.
    Yeast, 22(1): 57-70. [Abstract] [Full-text]
15. Immediate hypersensitivity to Malassezia furfur and Candida albicans mannans in vivo and in vitro.
    Allergy, 60(2): 238-42. [Abstract] [Full-text]
16. The effect of fixed orthodontic appliances on the oral carriage of Candida species and Enterobacteriaceae.
    Eur J Orthod, 26(6): 623-9. [Abstract] [Full-text]
17. Candida and antibiotic-associated diarrhoea.
    Clin Microbiol Infect, 11(1): 1-2. [Abstract] [Full-text]
18. Proteomics and physiology of erythritol-producing strains.
    J Chromatogr B Analyt Technol Biomed Life Sci, 815(1): 251-60. [Abstract] [Full-text]
19. Plasma membrane alteration is an early signaling event in doxorubicin-induced apoptosis in the yeast Candida utilis.
    Ann N Y Acad Sci, 1030: 369-76. [Abstract] [Full-text]
20. Differential expression of the NRG1 repressor controls species-specific regulation of chlamydospore development in Candida albicans and Candida dubliniensis.
    Mol Microbiol, 55(2): 637-52. [Abstract] [Full-text]
21. PMT family of Candida albicans: five protein mannosyltransferase isoforms affect growth, morphogenesis and antifungal resistance.
    Mol Microbiol, 55(2): 546-60. [Abstract] [Full-text]
22. Candida albicans protein kinase CaHsl1p regulates cell elongation and virulence.
    Mol Microbiol, 55(2): 381-95. [Abstract] [Full-text]
23. Epidemiology and antifungal susceptibility of Candida species isolated from blood: results of a 2-year multicentre study in Spain.
    Eur J Clin Microbiol Infect Dis, 24(1): 23-30. [Abstract] [Full-text]
24. Colonization of surfaces by phenolic compounds utilizing microorganisms.
    Environ Int, 31(2): 197-200. [Abstract] [Full-text]
25. CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species.
    Infect Immun, 73(2): 1239-42. [Abstract] [Full-text]
26. Deletion of the SSK1 response regulator gene in Candida albicans contributes to enhanced killing by human polymorphonuclear neutrophils.
    Infect Immun, 73(2): 865-71. [Abstract] [Full-text]
27. Enhanced killing of Candida albicans by human macrophages adherent to type 1 collagen matrices via induction of phagolysosomal fusion.
    Infect Immun, 73(2): 770-7. [Abstract] [Full-text]
28. Carbon source induced yeast-to-hypha transition in Candida albicans is dependent on the presence of amino acids and on the G-protein-coupled receptor Gpr1.
    Biochem Soc Trans, 33: 291-3. [Abstract] [Full-text]
29. Role of oxidative phosphorylation in histatin 5-induced cell death in Saccharomyces cerevisiae.
    Biotechnol Lett, 26(23): 1781-5. [Abstract] [Full-text]
30. Fine tuning of coenzyme specificity in family 2 aldo-keto reductases revealed by crystal structures of the Lys-274-->Arg mutant of Candida tenuis xylose reductase (AKR2B5) bound to NAD+ and NADP+.
    FEBS Lett, 579(3): 763-7. [Abstract] [Full-text]
31. Effects of cetylpyridinium chloride resistance and treatment on fluconazole activity versus Candida albicans.
    Antimicrob Agents Chemother, 49(2): 843-5. [Abstract] [Full-text]
32. Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole.
    Antimicrob Agents Chemother, 49(2): 783-7. [Abstract] [Full-text]
33. Multiechinocandin- and multiazole-resistant Candida parapsilosis isolates serially obtained during therapy for prosthetic valve endocarditis.
    Antimicrob Agents Chemother, 49(2): 767-9. [Abstract] [Full-text]
34. Mechanisms of azole resistance in clinical isolates of Candida glabrata collected during a hospital survey of antifungal resistance.
    Antimicrob Agents Chemother, 49(2): 668-79. [Abstract] [Full-text]
35. Interaction between posaconazole and amphotericin B in concomitant treatment against Candida albicans in vivo.
    Antimicrob Agents Chemother, 49(2): 638-42. [Abstract] [Full-text]
36. cDNA microarray analysis of differential gene expression in Candida albicans biofilm exposed to farnesol.
    Antimicrob Agents Chemother, 49(2): 584-9. [Abstract] [Full-text]
37. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Antimicrob Agents Chemother, 49(2): 512-7. [Abstract] [Full-text]
38. Risk factors for mammary candidosis among lactating women.
    J Obstet Gynecol Neonatal Nurs, 34(1): 37-45. [Abstract] [Full-text]
39. Comparison of image analysis software packages in the assessment of adhesion of microorganisms to mucosal epithelium using confocal laser scanning microscopy.
    J Microbiol Methods, 61(1): 105-26. [Abstract] [Full-text]
40. Candida krusei fungaemia: antifungal susceptibility and clinical presentation of an uncommon entity during 15 years in a single general hospital.
    J Antimicrob Chemother, 55(2): 188-93. [Abstract] [Full-text]
41. In vitro susceptibilities of bloodstream isolates of Candida species to six antifungal agents: results from a population-based active surveillance programme, Barcelona, Spain, 2002-2003.
    J Antimicrob Chemother, 55(2): 194-9. [Abstract] [Full-text]
42. Detection and identification of Candida species associated with Candida vaginitis by real-time PCR and pyrosequencing.
    Mol Cell Probes, 19(2): 145-52. [Abstract] [Full-text]
43. Comparison of phospholipase and proteinase activity in Candida albicans and C. dubliniensis.
    Mycoses, 48(1): 62-7. [Abstract] [Full-text]
44. Comparison of standard phenotypic assays with a PCR method to discriminate Candida albicans and C. dubliniensis.
    Mycoses, 48(1): 55-61. [Abstract] [Full-text]
45. Liquid growth conditions for abundant chlamydospore formation in Candida dubliniensis.
    Mycoses, 48(1): 50-4. [Abstract] [Full-text]
46. Reassessment of the in vitro synergistic effect of fluconazole with the non-steroidal anti-inflammatory agent ibuprofen against Candida albicans.
    Mycoses, 48(1): 38-41. [Abstract] [Full-text]
47. Use of magnetic beads to extract fungal DNA.
    Mycoses, 48(1): 3-7. [Abstract] [Full-text]
48. Clinical and mycological benefits of topical application of honey, olive oil and beeswax in diaper dermatitis.
    Clin Microbiol Infect, 11(2): 160-3. [Abstract] [Full-text]

© 2004-2008 Candida Research Today. All Rights Reserved.